BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun E, Motolani A, Campos L, Lu T. The Pivotal Role of NF-kB in the Pathogenesis and Therapeutics of Alzheimer’s Disease. IJMS 2022;23:8972. [DOI: 10.3390/ijms23168972] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Deng M, Yan W, Gu Z, Li Y, Chen L, He B. Anti-Neuroinflammatory Potential of Natural Products in the Treatment of Alzheimer’s Disease. Molecules 2023;28:1486. [DOI: 10.3390/molecules28031486] [Reference Citation Analysis]
2 Woodfield A, Gonzales T, Helmerhorst E, Laws S, Newsholme P, Porter T, Verdile G. Current Insights on the Use of Insulin and the Potential Use of Insulin Mimetics in Targeting Insulin Signalling in Alzheimer's Disease. Int J Mol Sci 2022;23. [PMID: 36555450 DOI: 10.3390/ijms232415811] [Reference Citation Analysis]
3 Bazzari FH, Bazzari AH. BACE1 Inhibitors for Alzheimer's Disease: The Past, Present and Any Future? Molecules 2022;27. [PMID: 36557955 DOI: 10.3390/molecules27248823] [Reference Citation Analysis]
4 Bhattacharya A, Singh R. Trans-resveratrol-3-o-b-glucoside, an alternative therapy for Alzheimer's disease, an in-silico approach.. [DOI: 10.21203/rs.3.rs-2243416/v1] [Reference Citation Analysis]
5 Ramasubbu K, Devi Rajeswari V. Impairment of insulin signaling pathway PI3K/Akt/mTOR and insulin resistance induced AGEs on diabetes mellitus and neurodegenerative diseases: a perspective review. Mol Cell Biochem 2022. [DOI: 10.1007/s11010-022-04587-x] [Reference Citation Analysis]